Is biopsy specimen microvessel density a useful prognostic marker in patients with T ( 2-4 ) M ( 0 ) esophageal cancer treated with chemoradiotherapy?
These results indicate that MVD using pretreatment biopsy specimens is a potentially useful prognostic marker for CRT in patients with T(2-4)M(0) esophageal cancer who are treated with CRT.
Titres of p17 and p24 IgG appeared to alter in the same manner. A progressive reduction in IgG titres and a low p17 IgG avidity were earlier predictors of disease progression than CD4 cell counts or p24 antigenaemia.